跳至主要内容
临床试验/NCT07720102
NCT07720102尚未招募不适用

Patient Reported Outcomes Following Percutaneous Lung Ablation

Mayo Clinic1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2026年9月1日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
Mayo Clinic
入组人数
50
试验地点
1
主要终点
Symptom severity following percutaneous lung ablation

研究概览

简要总结

This study evaluates satisfaction with percutaneous ablation and any symptoms experienced before and after the procedure in patients with lung tumors.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Undergoing percutaneous lung ablation

排除标准

  • Decline to participate in research

结局指标

主要结局

Symptom severity following percutaneous lung ablation

时间窗: Baseline (prior to ablation), 1 day, 3 days, 7 days, 1 month, 3 months

Assessed using a study-specific survey. Participants evaluate 5 symptoms (pain, fatigue, drowsiness, shortness of breath, and disturbed sleep), each on an 11-point Likert scale of 0-10 where 0=absence of symptoms and 10=as bas as you can imagine. Higher scores indicate greater severity of symptoms.

次要结局

未报告次要终点

研究者

发起方
Mayo Clinic
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验